BIOQUAL, Inc.
BIOQ
$55.00
-$1.00-1.79%
| 11/30/2024 | 08/31/2024 | 11/30/2023 | 11/30/2023 | 05/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 61.62M | 61.62M | 62.66M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 61.62M | 61.62M | 62.66M |
| Cost of Revenue | -- | -- | 50.80M | 50.80M | 50.06M |
| Gross Profit | -- | -- | 10.82M | 10.82M | 12.60M |
| SG&A Expenses | -- | -- | 11.77M | 11.77M | 11.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 62.57M | 62.57M | 61.56M |
| Operating Income | -- | -- | -947.60K | -947.60K | 1.10M |
| Income Before Tax | -- | -- | -741.50K | -741.50K | 1.13M |
| Income Tax Expenses | -- | -- | -283.80K | -283.80K | 297.70K |
| Earnings from Continuing Operations | -- | -- | -0.46 | -0.46 | 0.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -457.60K | -457.60K | 835.60K |
| EBIT | -- | -- | -947.60K | -947.60K | 1.10M |
| EBITDA | -- | -- | 1.58M | 1.58M | 3.38M |
| EPS Basic | -- | -- | -0.51 | -0.51 | 0.93 |
| Normalized Basic EPS | -- | -- | -0.52 | -0.52 | 0.79 |
| EPS Diluted | -- | -- | -0.52 | -0.52 | 0.93 |
| Normalized Diluted EPS | -- | -- | -0.52 | -0.52 | 0.79 |
| Average Basic Shares Outstanding | -- | -- | 3.58M | 3.58M | 3.58M |
| Average Diluted Shares Outstanding | -- | -- | 3.58M | 3.58M | 3.58M |
| Dividend Per Share | -- | -- | 0.50 | 0.50 | 0.50 |
| Payout Ratio | -- | -- | -97.73% | -97.73% | 107.04% |
